A clinical study to assess the efficacy of tuvarakadi cream in the managment of charmadala in the age group of 6 months to 2 year childrem with special reference to atopic dermatitis
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To evaluate efficacy of Tuvarakadi cream in the management of charmadala
研究概览
简要总结
This is a clinical study to assess the efficacy of tuvrakadi cream in the management of charmadala in the age group of 6 months to 2 year children with special reference to atopic dermatitis
Primary objective is to study the effectiveness of tuvarakadi cream as bahirparimarjana in the management of charmadala in kshreerap and kshreeranada balak in the timespan of 14 days.
Assessment of signs and symptoms will be done and observation will be drawn from the outcome of patient.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 6.00 Month(s) 至 2.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient having classical signs and symptoms of Vataj Charmadala.
- •Infants and toddlers between the Age group 6 months to 2 years.
- •Patients irrespective of sex, religion and socioeconomical status.
- •Patient of the parent who will give written consent will be included.
排除标准
- •Charmadala associated with sphota.
- •Patient with associated skin infections such as herpes simplex, herpes zoster, scabies, impetigo or lichen simplex chronicus and congenital syphilis.
- •Children having any other associated illness such as acute exacerbation of asthma or hey fever.
- •Children admitted in NICU and PICU.
- •Children receiving phototherapy.
- •Patient with more than 60 % body surface involvement.
- •Patient taking treatment from any other pathy for the same problem.
结局指标
主要结局
To evaluate efficacy of Tuvarakadi cream in the management of charmadala
时间窗: Treatment will be given for 14 days | Tuvarakadi will be given to the patient for external application. | Follow up and assessment will be done after7th day and 14th day. | Final observation will be recorded after | completion of treatment.
in the age group of 6 months to 2 year old children in time span of 14 days
时间窗: Treatment will be given for 14 days | Tuvarakadi will be given to the patient for external application. | Follow up and assessment will be done after7th day and 14th day. | Final observation will be recorded after | completion of treatment.
次要结局
- To observe adverse effect & evaluate the safety of Tuvarakadi cream in the management of charmadala in(the age group of 6 months to 2 year old children in the time span of 14 days)